Outcomes of stereotactic body radiotherapy for unresectable primary or recurrent cholangiocarcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Outcomes of stereotactic body radiotherapy for unresectable primary or recurrent cholangiocarcinoma

Published:2014 Issue:3 Volume:32 Page:163
ISSN:2234-1900
Container-title:Radiation Oncology Journal
language:en
Short-container-title:Radiat Oncol J

Author:

Jung Da Hoon¹,Kim Mi-Sook¹,Cho Chul Koo¹,Yoo Hyung Jun¹,Jang Won Il¹,Seo Young Seok¹,Paik Eun Kyung¹,Kim Kum Bae¹,Han Chul Ju²,Kim Sang Bum³

Affiliation:

1. Department of Radiation Oncology, Korea Institute of Radiological & Medical Sciences, Seoul, Korea.

2. Department of Internal Medicine, Korea Institute of Radiological & Medical Sciences, Seoul, Korea.

3. Department of Surgical Oncology, Korea Institute of Radiological & Medical Sciences, Seoul, Korea.

Publisher

Korean Society for Therapeutic Radiology and Oncology

Subject

Radiology, Nuclear Medicine and imaging,Oncology

Link

http://synapse.koreamed.org/pdf/10.3857/roj.2014.32.3.163

Reference17 articles.

1. Surgical Management of Intrahepatic Cholangiocarcinoma - A Population-Based Study

2. Palliation of hepatic tumors

3. Clinical outcomes and toxicity using Stereotactic Body Radiotherapy (SBRT) for advanced cholangiocarcinoma

4. Limitations of conventional doses of chemoradiation for unresectable biliary cancer

5. The impact of radiation dose in combined external beam and intraluminal IR-192 brachytherapy for bile duct cancer

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of Unresectable Cholangiocarcinoma Using Modern Radiation Therapy Techniques;Digestive Disease Interventions;2024-07-17

2. The Current Role of Radiation in the Management of Cholangiocarcinoma—A Narrative Review;Cancers;2024-05-04

3. Survival and Toxicity in Patients with Unresectable or Inoperable Biliary Tract Cancers with Ablative Radiotherapy versus Non-Ablative Chemoradiation;Advances in Radiation Oncology;2023-12

4. Intrahepatic Cholangiocarcinoma - Where Do We Stand Today? Literature Review;CHIRURGIA-BUCHAREST;2023

5. Mechanism of postoperative recurrence and metastasis of intrahepatic cholangiocellular carcinoma and clinical prevention and treatment strategy;World Chinese Journal of Digestology;2023-09-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3